Disentangling neuroimmune landscapes across peripheral activation paradigms resolves divergent glial state programs

Mahesh Chandra Kodali1,2,3,4, Zhengjun Wang3, Geng Lin3

  • 1Department of Neurology, Harvard Medical School, Boston, MA, 02115, USA.

Research Square
|February 27, 2026
PubMed
Summary

Distinct dosing of lipopolysaccharide (LPS) differentially impacts the brain. High-dose LPS causes neuroinflammation, while repeated low-dose LPS promotes protective microglial phagocytosis without inflammation.

Related Concept Videos